SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 152 filers reported holding SERES THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,985,460 | -47.8% | 1,254,395 | +5.1% | 0.00% | -100.0% |
Q2 2023 | $5,718,762 | +147.7% | 1,193,896 | +193.2% | 0.00% | – |
Q1 2023 | $2,308,808 | +14.5% | 407,197 | +13.0% | 0.00% | – |
Q4 2022 | $2,017,148 | +32.7% | 360,205 | +52.1% | 0.00% | – |
Q3 2022 | $1,520,000 | +401.7% | 236,841 | +168.0% | 0.00% | – |
Q2 2022 | $303,000 | -81.0% | 88,368 | -60.4% | 0.00% | – |
Q1 2022 | $1,591,000 | +54.9% | 223,401 | +81.3% | 0.00% | – |
Q4 2021 | $1,027,000 | -40.6% | 123,208 | -50.4% | 0.00% | – |
Q3 2021 | $1,728,000 | -51.5% | 248,325 | +66.4% | 0.00% | – |
Q2 2021 | $3,560,000 | +13.7% | 149,266 | -1.8% | 0.00% | – |
Q1 2021 | $3,130,000 | -26.4% | 152,003 | -12.5% | 0.00% | -100.0% |
Q4 2020 | $4,255,000 | +636.2% | 173,663 | +750.3% | 0.00% | – |
Q3 2020 | $578,000 | +970.4% | 20,424 | +82.3% | 0.00% | – |
Q2 2020 | $54,000 | +80.0% | 11,203 | +33.7% | 0.00% | – |
Q1 2020 | $30,000 | -9.1% | 8,382 | -12.8% | 0.00% | – |
Q4 2019 | $33,000 | -37.7% | 9,612 | -27.3% | 0.00% | – |
Q3 2019 | $53,000 | -63.4% | 13,223 | -70.8% | 0.00% | – |
Q2 2019 | $145,000 | -57.0% | 45,288 | -7.8% | 0.00% | – |
Q1 2019 | $337,000 | +39.3% | 49,101 | -8.3% | 0.00% | – |
Q4 2018 | $242,000 | -46.2% | 53,547 | -9.7% | 0.00% | – |
Q3 2018 | $450,000 | +43.3% | 59,331 | +62.6% | 0.00% | – |
Q2 2018 | $314,000 | +223.7% | 36,489 | +175.0% | 0.00% | – |
Q1 2018 | $97,000 | -25.4% | 13,267 | +2.7% | 0.00% | – |
Q4 2017 | $130,000 | -54.2% | 12,921 | -27.1% | 0.00% | – |
Q3 2017 | $284,000 | +4.8% | 17,734 | -26.0% | 0.00% | – |
Q2 2017 | $271,000 | +0.4% | 23,981 | +0.1% | 0.00% | – |
Q1 2017 | $270,000 | +114.3% | 23,948 | +88.7% | 0.00% | – |
Q4 2016 | $126,000 | +100.0% | 12,692 | +150.7% | 0.00% | – |
Q3 2016 | $63,000 | -64.2% | 5,062 | -16.2% | 0.00% | – |
Q2 2016 | $176,000 | +23.9% | 6,039 | +12.9% | 0.00% | – |
Q1 2016 | $142,000 | -48.0% | 5,349 | -31.1% | 0.00% | – |
Q4 2015 | $273,000 | +160.0% | 7,758 | +118.3% | 0.00% | – |
Q3 2015 | $105,000 | – | 3,554 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Flagship Pioneering Inc. | 23,117,045 | $55,018,567 | 3.99% |
Lion Point Capital, LP | 691,803 | $1,646,491 | 0.73% |
Eversept Partners, LP | 2,352,556 | $5,599,083 | 0.47% |
Soleus Capital Management, L.P. | 1,820,983 | $4,333,940 | 0.40% |
Simplify Asset Management Inc. | 550,626 | $1,310,490 | 0.15% |
Avoro Capital Advisors LLC | 2,500,000 | $5,950,000 | 0.09% |
IRONWOOD INVESTMENT MANAGEMENT LLC | 45,419 | $108,097 | 0.07% |
Knott David M Jr | 70,000 | $167 | 0.06% |
XTX Topco Ltd | 150,097 | $357,231 | 0.06% |
FEDERATED HERMES, INC. | 8,981,717 | $21,376,486 | 0.06% |